{
"author": {
"name": "Jef Feeley",
"webUrl": "/author/profile/jef-feeley/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 35,
"social": [],
"articles": [
{
"uri": "/2022/05/06/pension-fund-challenges-musks-twitter-buyout/",
"title": "Police pension fund challenges Musk's Twitter buyout",
"byline": "Jef Feeley",
"kicker": "News",
"prettyDate": "May 06, 2022",
"timeToRead": "3 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2022/05/Elon-Musk-Naresh777-at-Shutterstock.jpg",
"width": "617",
"height": "413"
},
"authors": [
{
"webUrl": "/author/profile/jef-feeley/",
"name": "Jef Feeley"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "\"Agreements\" Musk made with other Twitter investors make him an \"interested shareholder\" who must wait three years to close the deal, fund says.",
"body": null
},
{
"uri": "/2022/03/10/insurers-refuse-to-pick-up-the-bill-for-billions-in-opioid-claims/",
"title": "Insurers refuse to pick up the bill for billions in opioid claims",
"byline": "Jef Feeley",
"kicker": "News",
"prettyDate": "March 10, 2022",
"timeToRead": "5 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/11/settlement-money-court-gavel.jpg",
"width": "617",
"height": "410"
},
"authors": [
{
"webUrl": "/author/profile/jef-feeley/",
"name": "Jef Feeley"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Insurers are taking legal action after a Delaware court ruled Chubb didn't have to pay to defend Rite Aid against thousands of lawsuits.",
"body": null
},
{
"uri": "/2021/05/06/opioid-distributors-sold-mountain-of-pills-lawyer-says-in-latest-trial/",
"title": "Opioid distributors sold 'mountain of pills,' lawyer says in latest trial",
"byline": "Jef Feeley",
"kicker": "News",
"prettyDate": "May 06, 2021",
"timeToRead": "4 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/02/OpioidsNationally.jpg",
"width": "600",
"height": "400"
},
"authors": [
{
"webUrl": "/author/profile/jef-feeley/",
"name": "Jef Feeley"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "West Virginia plaintiffs want distributors to pay $2.6B to beef up treatment and policing budgets strained by years of opioid overdoses.",
"body": null
},
{
"uri": "/2020/11/26/cigna-ceo-board-sued-for-black-ops-effort-to-kill-anthem-deal/",
"title": "Cigna CEO, board sued for 'black ops' effort to kill Anthem deal",
"byline": "Michael Leonard and Jef Feeley",
"kicker": "News",
"prettyDate": "November 26, 2020",
"timeToRead": "4 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/09/handshakebusinessmenshadowmi600-resize-600x338-men.jpg",
"width": "0",
"height": "0"
},
"authors": [
{
"webUrl": "/author/profile/michael-leonard/",
"name": "Michael Leonard"
},
{
"webUrl": "/author/profile/jef-feeley/",
"name": "Jef Feeley"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Cigna CEO David Cordani allegedly sought to \"poison\" the deal after failing to secure the top post in the merged company.",
"body": null
},
{
"uri": "/2020/08/06/doj-seeks-11-billion-in-purdue-pharma-bankruptcy-case/",
"title": "DOJ seeks $11 billion in Purdue Pharma bankruptcy case",
"byline": "Jef Feeley",
"kicker": "News",
"prettyDate": "August 06, 2020",
"timeToRead": "4 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/09/Purdue-Pharma-Headquarters-Article-201909091737.jpg",
"width": "620",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/jef-feeley/",
"name": "Jef Feeley"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The sum includes $6.2 billion on the criminal side and about $5 billion for tax dollars spent battling the U.S. opioid epidemic.",
"body": null
},
{
"uri": "/2020/06/24/walmart-faces-pension-fund-lawsuits-over-internal-opioid-files/",
"title": "Walmart faces pension-fund lawsuits over internal opioid files",
"byline": "Jef Feeley",
"kicker": "News",
"prettyDate": "June 24, 2020",
"timeToRead": "3 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/06/1007walmart_ap.jpg",
"width": "616",
"height": "411"
},
"authors": [
{
"webUrl": "/author/profile/jef-feeley/",
"name": "Jef Feeley"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The funds own Walmart shares and allege executives ensured a steady stream of opioids to so-called pill mills.",
"body": null
},
{
"uri": "/2019/09/16/purdue-pharma-files-for-bankruptcy/",
"title": "Purdue Pharma files for bankruptcy",
"byline": "Jef Feeley and Steven Church",
"kicker": "News",
"prettyDate": "September 16, 2019",
"timeToRead": "6 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/09/Purdue-Pharma-Headquarters-Article-201909091737.jpg",
"width": "620",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/jef-feeley/",
"name": "Jef Feeley"
},
{
"webUrl": "/author/profile/steven-church/",
"name": "Steven Church"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The Chapter 11 filing on Sunday is designed to short-circuit more than 2,000 lawsuits against Purdue and its owners.",
"body": null
},
{
"uri": "/2019/08/28/purdue-proposes-11-5b-opioid-settlement/",
"title": "Purdue proposes $11.5B opioid settlement",
"byline": "Jef Feeley and Riley Griffin",
"kicker": "News",
"prettyDate": "August 28, 2019",
"timeToRead": "6 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2017/12/13OpioidsNationally.jpg",
"width": "600",
"height": "400"
},
"authors": [
{
"webUrl": "/author/profile/jef-feeley/",
"name": "Jef Feeley"
},
{
"webUrl": "/author/profile/riley-griffin/",
"name": "Riley Griffin"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Under the proposal, Purdue will file for bankruptcy, hand itself over to a trust and sell its overseas drugmaker.",
"body": null
},
{
"uri": "/2019/08/22/drugmaker-to-pay-11-million-settlement-to-avoid-opioid-trial/",
"title": "Drugmaker to pay $11 million settlement to avoid opioid trial",
"byline": "By Jef Feeley and Riley Griffin",
"kicker": "News",
"prettyDate": "August 22, 2019",
"timeToRead": "5 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/opioid-abuse-crop.jpg",
"width": "600",
"height": "338"
},
"authors": [
{
"webUrl": "/author/profile/by-jef-feeley/",
"name": "By Jef Feeley"
},
{
"webUrl": "/author/profile/riley-griffin/",
"name": "Riley Griffin"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The deal resolves only two cases set for trial in October and leaves intact lawsuits filed by more than 2,000 local governments.",
"body": null
},
{
"uri": "/2019/06/10/insys-files-for-bankruptcy-amid-opioid-liabilities/",
"title": "Insys files for bankruptcy amid opioid liabilities",
"byline": "Riley Griffin and Jef Feeley",
"kicker": "News",
"prettyDate": "June 10, 2019",
"timeToRead": "5 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/06/opioid-abuse-crop.jpg",
"width": "600",
"height": "338"
},
"authors": [
{
"webUrl": "/author/profile/riley-griffin/",
"name": "Riley Griffin"
},
{
"webUrl": "/author/profile/jef-feeley/",
"name": "Jef Feeley"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Insys is the first drugmaker to seek bankruptcy protection from its creditors as a result of legal action related to the U.S. opioid epidemic. ",
"body": null
}
]
}
}
